Literature DB >> 19027293

Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.

Mark P Wentland1, Rongliang Lou, Qun Lu, Yigong Bu, Melissa A VanAlstine, Dana J Cohen, Jean M Bidlack.   

Abstract

A series of 15 novel opioid derivatives were made where the prototypic phenolic-OH group of traditional opioids was replaced by a carboxamido (CONH(2)) group. For 2,6-methano-3-benzazocines and morphinans similar or, in a few instances, enhanced affinity for mu, delta and kappa opioid receptors was observed when the OH-->CONH(2) switch was applied. For 4,5alpha-epoxymorphinans, binding affinities for the corresponding carboxamide derivatives were much lower than the OH partner consistent with our pharmacophore hypothesis concerning carboxamide bioactive conformation. The active metabolite of tramadol and its carboxamide counterpart had comparable affinities for the three receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027293     DOI: 10.1016/j.bmcl.2008.10.134

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Semisynthetic neoclerodanes as kappa opioid receptor probes.

Authors:  Kimberly M Lovell; Tamara Vasiljevik; Juan J Araya; Anthony Lozama; Katherine M Prevatt-Smith; Victor W Day; Christina M Dersch; Richard B Rothman; Eduardo R Butelman; Mary Jeanne Kreek; Thomas E Prisinzano
Journal:  Bioorg Med Chem       Date:  2012-03-01       Impact factor: 3.641

Review 2.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

3.  Syntheses of novel high affinity ligands for opioid receptors.

Authors:  Mark P Wentland; Rongliang Lou; Qun Lu; Yigong Bu; Christoph Denhardt; Jin Jin; Rakesh Ganorkar; Melissa A VanAlstine; Chengyun Guo; Dana J Cohen; Jean M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2009-02-25       Impact factor: 2.823

4.  Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids.

Authors:  Xuelian Jia; Heather L Ciallella; Daniel P Russo; Linlin Zhao; Morgan H James; Hao Zhu
Journal:  ACS Sustain Chem Eng       Date:  2021-03-04       Impact factor: 8.198

5.  Evaluation of opioid modulation in major depressive disorder.

Authors:  Elliot Ehrich; Ryan Turncliff; Yangchun Du; Richard Leigh-Pemberton; Emilio Fernandez; Reese Jones; Maurizio Fava
Journal:  Neuropsychopharmacology       Date:  2014-12-18       Impact factor: 7.853

6.  Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.

Authors:  Courtney M Cameron; Steven Nieto; Lucienne Bosler; Megan Wong; Isabel Bishop; Larissa Mooney; Catherine M Cahill
Journal:  Adv Drug Alcohol Res       Date:  2021-08-03

7.  μ Opioid receptor: novel antagonists and structural modeling.

Authors:  Teresa Kaserer; Aquilino Lantero; Helmut Schmidhammer; Mariana Spetea; Daniela Schuster
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

8.  Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands.

Authors:  Zhijun Wu; Victor J Hruby
Journal:  ACS Omega       Date:  2019-10-09

9.  Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.

Authors:  Phu N Tran; Jiansong Sheng; Aaron L Randolph; Claudia Alvarez Baron; Nicolas Thiebaud; Ming Ren; Min Wu; Lars Johannesen; Donna A Volpe; Dakshesh Patel; Ksenia Blinova; David G Strauss; Wendy W Wu
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.